EuropaBio calls for innovative policies while maintaining safety standards

EuropaBio, the trade association for the European biotech industry, has called on European Union policymakers to continue promoting innovation while maintaining safety and efficacy standards.

Participating in a conference organized by the European Commission in Brussels titled 50 years of EU Pharma Legislation: Achievements and Future Perspectives, EuropaBio’s contribution was one of many issues addressed, including access and safety to medicine and the role of legislation in promoting innovation.

Nathalie Moll, secretary general of EuropaBio, said: “Europe has clearly come a long way in terms of protecting patient safety and guaranteeing the quality and efficacy of new medicines. We call on the EU drug regulatory network to maintain such high standards in the future while at the same time allowing enough flexibility for the healthcare biotech industry to continue to innovate.”